Journal article
Physician decision making in selection of second‐line treatments in immune thrombocytopenia in children
Abstract
Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder which presents with isolated thrombocytopenia and risk of hemorrhage. While most children with ITP promptly recover with or without drug therapy, ITP is persistent or chronic in others. When needed, how to select second-line therapies is not clear. ICON1, conducted within the Pediatric ITP Consortium of North America (ICON), is a prospective, observational, longitudinal …
Authors
Grace RF; Despotovic JM; Bennett CM; Bussel JB; Neier M; Neunert C; Crary SE; Pastore YD; Klaassen RJ; Rothman JA
Journal
American Journal of Hematology, Vol. 93, No. 7, pp. 882–888
Publisher
Wiley
Publication Date
July 2018
DOI
10.1002/ajh.25110
ISSN
0361-8609